NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas

Abstract The tumor suppressor gene neurofibromin 1 (NF1) is a major regulator of the RAS‐MAPK pathway. NF1 mutations occur in lung cancer but were not extensively explored. We hypothesized that NF1‐mutated tumors could define a specific population with a distinct clinical and molecular profile. We p...

Full description

Bibliographic Details
Main Authors: Camille Tlemsani, Nicolas Pécuchet, Aurelia Gruber, Ingrid Laurendeau, Claire Danel, Marc Riquet, Françoise Le Pimpec‐Barthes, Elizabeth Fabre, Audrey Mansuet‐Lupo, Diane Damotte, Marco Alifano, Armelle Luscan, Benoit Rousseau, Dominique Vidaud, Jennifer Varin, Beatrice Parfait, Ivan Bieche, Karen Leroy, Pierre Laurent‐Puig, Benoit Terris, Helene Blons, Michel Vidaud, Eric Pasmant
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:Cancer Medicine
Subjects:
lung adenocarcinoma
molecular subtype
next generation sequencing
NF1
RAS‐MAPK pathway
Online Access:https://doi.org/10.1002/cam4.2175

Internet

https://doi.org/10.1002/cam4.2175

Similar Items